Northeast Financial Consultants’s Opus Genetics IRD Stock Holding History

Northeast Financial Consultants’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-313	Closed	-$8K	–	339
2019 Q1	$8K	Hold	313	–	–	﹤0.01%	316
2018 Q4	$14K	Buy	+313	New	+$18.3K	﹤0.01%	159
2018 Q3	–	Sell	-313	Closed	-$21K	–	177
2018 Q2	$21K	Hold	313	–	–	0.01%	145
2018 Q1	$22K	Hold	313	–	–	0.01%	146
2017 Q4	$30K	Hold	313	–	–	0.01%	153
2017 Q3	$36K	Hold	313	–	–	0.01%	150
2017 Q2	$43K	Hold	313	–	–	0.02%	142
2017 Q1	$76K	Hold	313	–	–	0.03%	148
2016 Q4	$21K	Hold	313	–	–	0.01%	142
2016 Q3	$31K	Hold	313	–	–	0.01%	154
2016 Q2	$38K	Hold	313	–	–	0.02%	149
2016 Q1	$50K	Hold	313	–	–	0.03%	135
2015 Q4	$54K	Hold	313	–	–	0.03%	130
2015 Q3	$78K	Hold	313	–	–	0.04%	139
2015 Q2	$91K	Hold	313	–	–	0.04%	149
2015 Q1	$109K	Hold	313	–	–	0.05%	140
2014 Q4	$105K	Hold	313	–	–	0.06%	131
2014 Q3	$121K	Hold	313	–	–	0.07%	130
2014 Q2	$130K	Hold	313	–	–	0.07%	126
2014 Q1	$162K	Buy	+313	New	+$169K	0.1%	115

Other funds holding IRD

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northeast Financial Consultants's IRD Position: Q2 2019 in Review

Northeast Financial Consultants sold out of Opus Genetics (IRD) in Q2 2019, closing a stake of 313 shares — an estimated $8K sold.

Northeast Financial Consultants first reported a position in IRD in Q1 2014 and held it in 20 quarters. The position peaked at $162K in Q1 2014. 16 funds tracked by Wall St. Rank hold IRD as of Q2 2019.

Northeast Financial Consultants reported no remaining Opus Genetics position as of Q2 2019 after selling out during the quarter.
Northeast Financial Consultants sold 313 Opus Genetics shares in Q2 2019, an estimated $8K.
Northeast Financial Consultants first reported a position in Opus Genetics in Q1 2014 and held it in 20 quarters.
Northeast Financial Consultants's Opus Genetics position peaked at $162K in Q1 2014.
16 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2019.

Based on Northeast Financial Consultants's 13F filing for Q2 2019, filed 9 Aug 2019.